302 related articles for article (PubMed ID: 1497160)
41. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.
Nieminen P; Hakama M; Viikki M; Tarkkanen J; Anttila A
Int J Cancer; 2003 Jan; 103(3):422-6. PubMed ID: 12471627
[TBL] [Abstract][Full Text] [Related]
42. Abnormal Pap smear follow-up in a high-risk population.
Engelstad LP; Stewart SL; Nguyen BH; Bedeian KL; Rubin MM; Pasick RJ; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1015-20. PubMed ID: 11588126
[TBL] [Abstract][Full Text] [Related]
43. Family planning provider referral, facilitation behavior, and patient follow-up for abnormal Pap smears.
Felix HC; Bronstein J; Bursac Z; Stewart MK; Foushee HR; Klapow J
Public Health Rep; 2009; 124(5):733-44. PubMed ID: 19753952
[TBL] [Abstract][Full Text] [Related]
44. Human papilloma virus infection and cervical dysplasia.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):853-7. PubMed ID: 23272541
[TBL] [Abstract][Full Text] [Related]
45. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
[TBL] [Abstract][Full Text] [Related]
46. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
Budge M; Halford J; Haran M; Mein J; Wright G
Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
[TBL] [Abstract][Full Text] [Related]
47. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.
Deerasamee S; Srivatanakul P; Sriplung H; Nilvachararung S; Tansuwan U; Pitakpraiwan P; Kaewkungwal J; Singhasivanon P; Nimnakorn P; Sankaranarayanan R
Asian Pac J Cancer Prev; 2007; 8(4):547-56. PubMed ID: 18260727
[TBL] [Abstract][Full Text] [Related]
48. Cervical neoplasia in pap smears: risk of cervical intra-epithelial neoplasia (CIN) after negative or no prior smears in a population without a mass screening programme.
Forsmo S; Jacobsen BK; Stalsberg H
Int J Epidemiol; 1996 Feb; 25(1):53-8. PubMed ID: 8666505
[TBL] [Abstract][Full Text] [Related]
49. Papanicolaou screening in an urgent care setting.
Dunn TS; Jazbec A; Awad R; Batal H
Am J Obstet Gynecol; 2005 Apr; 192(4):1084-6. PubMed ID: 15846184
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the atypical Pap smear.
Jones DE; Creasman WT; Dombroski RA; Lentz SS; Waeltz JL
Am J Obstet Gynecol; 1987 Sep; 157(3):544-9. PubMed ID: 3631155
[TBL] [Abstract][Full Text] [Related]
51. Papanicolaou smear screening and cervical cancer. What can you expect?
Stenkvist B; Bergström R; Eklund G; Fox CH
JAMA; 1984 Sep; 252(11):1423-6. PubMed ID: 6471269
[TBL] [Abstract][Full Text] [Related]
52. Age at time of first intercourse v. chronologic age as a basis for Pap smear screening.
Wright VC; Riopelle MA
Can Med Assoc J; 1982 Jul; 127(2):127-31. PubMed ID: 7093858
[TBL] [Abstract][Full Text] [Related]
53. Intraepithelial neoplasia of the uterine cervix in the teenager.
Feldman MJ; Kent DR; Pennington RL
Cancer; 1978 Apr; 41(4):1405-8. PubMed ID: 639001
[TBL] [Abstract][Full Text] [Related]
54. Papanicolaou smears in Victoria: are the wrong women being screened?
Mitchell H; Drake M; Medley G
Med J Aust; 1987 Dec 7-21; 147(11-12):559-60. PubMed ID: 3696044
[TBL] [Abstract][Full Text] [Related]
55. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
[TBL] [Abstract][Full Text] [Related]
56. [Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].
Geertsen M; Bais AG; Beerman H; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2430-4. PubMed ID: 14694554
[TBL] [Abstract][Full Text] [Related]
57. Cost-yield of routine Papanicolaou smear screening in a clinic for sexually transmitted diseases.
Tavelli BG; Judson FN; Hetrick AE; Root CJ
Sex Transm Dis; 1985; 12(3):110-3. PubMed ID: 3929404
[TBL] [Abstract][Full Text] [Related]
58. [Estimated results of prophylactic physical examinations detecting cervical cancer in Center of Oncology in Bydgoszcz in years 2001-2003].
Mierzwa T; Grabiec M; Walentowicz M
Ginekol Pol; 2005 Sep; 76(9):693-8. PubMed ID: 16417080
[TBL] [Abstract][Full Text] [Related]
59. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
60. Organization and evolution of organized cervical cytology screening in Thailand.
Khuhaprema T; Attasara P; Srivatanakul P; Sangrajrang S; Muwonge R; Sauvaget C; Sankaranarayanan R
Int J Gynaecol Obstet; 2012 Aug; 118(2):107-11. PubMed ID: 22613493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
